Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.39b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
9th Apr 202411:17 amRNSTransaction in Own Shares
9th Apr 202410:22 amRNSAnnual Financial Report
5th Apr 202411:59 amRNSTransaction in Own Shares
3rd Apr 20243:48 pmRNSTransaction in Own Shares
3rd Apr 202410:33 amRNSCirc re. Scrip Dividend Scheme
2nd Apr 202411:53 amRNSTransaction in Own Shares
28th Mar 202411:04 amRNSTotal Voting Rights
28th Mar 202410:56 amRNSTransaction in Own Shares
27th Mar 202410:11 amRNSTransaction in Own Shares
26th Mar 20241:24 pmRNSTransaction in Own Shares
25th Mar 20242:13 pmRNSTransaction in Own Shares
25th Mar 202410:23 amRNSBlock listing Interim Review
22nd Mar 202411:34 amRNSTransaction in Own Shares
21st Mar 202411:06 amRNSTransaction in Own Shares
19th Mar 20249:49 amRNSDirector/PDMR Shareholding
13th Mar 202411:21 amRNSTransaction in Own Shares
13th Mar 20248:59 amRNSPT HERO SUPERMARKET TBK FULL YEAR 2023 RESULTS
12th Mar 202410:08 amRNSDirector/PDMR Shareholding
12th Mar 20249:57 amRNSCorrection: Director/PDMR Shareholding
11th Mar 202410:15 amRNSTransaction in Own Shares
7th Mar 202412:21 pmRNS2023 Preliminary Results
7th Mar 202412:02 pmRNS2023 Preliminary Results
7th Mar 202411:01 amRNS2023 Preliminary Results
7th Mar 202410:04 amRNS2023 Preliminary Results
1st Mar 202410:14 amRNSChange of Singapore Branch Registrar
29th Feb 202410:54 amRNSTotal Voting Rights
27th Feb 202410:54 amRNSJC&C - 2023 FY Results and Dividend
27th Feb 202410:38 amRNSPT Astra – 2023 Full Year Financial Statements
20th Feb 20249:38 amRNSDirector/PDMR Shareholding
6th Feb 20249:40 amRNSDirector/PDMR Shareholding
2nd Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 202410:44 amRNSTotal Voting Rights
31st Jan 202410:43 amRNSTransaction in Own Shares
23rd Jan 202410:45 amRNSTransaction in Own Shares
22nd Jan 202410:47 amRNSDirector/PDMR Shareholding
18th Jan 202411:09 amRNSTransaction in Own Shares
18th Jan 20249:36 amRNSDirector/PDMR Shareholding
17th Jan 202410:40 amRNSTransaction in Own Shares
16th Jan 202411:31 amRNSTransaction in Own Shares
15th Jan 202410:57 amRNSTransaction in Own Shares
12th Jan 202411:04 amRNSTransaction in Own Shares
11th Jan 202411:56 amRNSTransaction in Own Shares
10th Jan 202411:07 amRNSTransaction in Own Shares
9th Jan 202411:01 amRNSTransaction in Own Shares
29th Dec 20239:31 amRNSTotal Voting Rights
6th Dec 202310:30 amRNSDirector/PDMR Shareholding
5th Dec 202310:53 amRNSTransaction in Own Shares
1st Dec 202311:27 amRNSTransaction in Own Shares
24th Nov 20239:17 amRNSDirectorate Changes
9th Nov 20239:59 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.